BD0004956
4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylicacid , 95% , 417717-21-6
| Pack Size | Price | Stock | Quantity |
| 50mg | RMB549.60 | In Stock |
|
| 100mg | RMB862.40 | In Stock |
|
| 250mg | RMB1440.00 | In Stock |
|
| 1g | RMB3886.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 599.5±50.0 °C(Predicted) |
| Density | 1.50±0.1 g/cm3(Predicted) |
| pka | 2.74±0.30(Predicted) |
Description and Uses
Desamino Hydroxy Lenvatinib serves as a reagent for the synthesis of urea derivatives containing nitrogenous aromatic ring compounds that functions as angiogenesis inhibitors for treatment of diseases. It is also a derivative compound of Lenvatinib (L329400) that serves as orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 |
